The media is abuzz this week with the news that megastar Angelina Jolie underwent a prophylactic double mastectomy after learning she tested positive for the BRCA gene mutation. She kept the decision and the surgery secret until four days after the procedure was done.
By breaking her silence and speaking out about it, she has used her celebrity status to shine a spotlight on breast cancer and the genetic mutation of BRCA1 and BRCA2, which are often called the breast cancer genes. These mutations are known to increase the risk of getting breast or ovarian cancer by 60 percent. Jolie said that doctors quoted her risk to be at 87 percent.
With someone so popular who relies on her looks to make a living taking this drastic step, the average woman might wonder if testing for the mutations and getting preventative mastectomies might be the right choice for her.
While raising awareness about this issue is important, it can also create confusion and fear. Getting tested alone is a huge step and should not be done lightly.
Testing for the BRCA genetic mutation is done by administering a simple blood test, but it is not always covered by insurance. At around $3000, the cost can be quite prohibitive for most people.
Experts recommend that only the 2 percent of women who have a family health history that makes them more likely to have the BRCA mutation be tested. Someone who has two first-generation relatives (mother, sister, daughter, etc.) who were diagnosed with breast cancer, would probably be a good candidate for this test.
Here are the guidelines from Cancer.gov that you should consider before deciding on BRCA testing.
For women who are not of Ashkenazi Jewish descent:
1. Two first-degree relatives diagnosed with breast cancer, with at least one being diagnosed by age 50 or younger
2. Three or more first-degree or second-degree (grandmother, aunt) relatives diagnosed with breast cancer regardless of their age at diagnosis
3. A combination of first- and second-degree relatives diagnosed with breast cancer and ovarian cancer (one cancer type per person)